These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38761346)

  • 1. Clinical and functional characterization of a novel KCNJ11 (c.101G > A, p.R34H) mutation associated with maturity-onset diabetes mellitus of the young type 13.
    Lv X; Gao J; Yang J; Zou Y; Chen J; Sun Y; Song J; Liu Y; Wang L; Xia L; Yu S; Wei Z; Chen L; Hou X
    Endocrine; 2024 Nov; 86(2):515-527. PubMed ID: 38761346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature.
    He B; Li X; Zhou Z
    J Diabetes; 2021 Jan; 13(1):19-32. PubMed ID: 32935446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.
    Vedovato N; Cliff E; Proks P; Poovazhagi V; Flanagan SE; Ellard S; Hattersley AT; Ashcroft FM
    Diabetologia; 2016 Jul; 59(7):1430-1436. PubMed ID: 27118464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Functional Characteristics of a Novel
    Sun Y; Qu J; Wang J; Zhao R; Wang C; Chen L; Hou X
    J Diabetes Res; 2021; 2021():7136869. PubMed ID: 33604390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation c.685G>A:p.E229K in the KCNJ11 gene: A case report of maturity-onset diabetes of the young13.
    Song X; Cao Y; Ye J; Dai W; Zhang S; Ye S
    Medicine (Baltimore); 2022 Sep; 101(39):e30668. PubMed ID: 36181023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
    Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
    BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated
    Bowman P; McDonald TJ; Knight BA; Flanagan SE; Leveridge M; Spaull SR; Shields BM; Hammersley S; Shepherd MH; Andrews RC; Patel KA; Hattersley AT
    BMJ Open Diabetes Res Care; 2019; 7(1):e000721. PubMed ID: 31908791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
    D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
    Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life.
    Vedovato N; Salguero MV; Greeley SAW; Yu CH; Philipson LH; Ashcroft FM
    Diabetologia; 2024 May; 67(5):940-951. PubMed ID: 38366195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.
    Bonnefond A; Philippe J; Durand E; Dechaume A; Huyvaert M; Montagne L; Marre M; Balkau B; Fajardy I; Vambergue A; Vatin V; Delplanque J; Le Guilcher D; De Graeve F; Lecoeur C; Sand O; Vaxillaire M; Froguel P
    PLoS One; 2012; 7(6):e37423. PubMed ID: 22701567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation.
    Griscelli F; Feraud O; Ernault T; Oudrihri N; Turhan AG; Bonnefond A; Froguel P; Bennaceur-Griscelli A
    Stem Cell Res; 2017 Aug; 23():178-181. PubMed ID: 28925365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.
    Abbasi F; Saba S; Ebrahim-Habibi A; Sayahpour FA; Amiri P; Larijani B; Amoli MM
    Mol Diagn Ther; 2012 Apr; 16(2):109-14. PubMed ID: 22471336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.
    Lau E; Correia C; Freitas P; Nogueira C; Costa M; Saavedra A; Costa C; Carvalho D; Fontoura M
    Arch Endocrinol Metab; 2015 Dec; 59(6):559-61. PubMed ID: 26331221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.
    Yorifuji T; Nagashima K; Kurokawa K; Kawai M; Oishi M; Akazawa Y; Hosokawa M; Yamada Y; Inagaki N; Nakahata T
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3174-8. PubMed ID: 15784703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synonymous
    Chen C; Piao Y; Sang Y
    Mol Genet Metab Rep; 2024 Mar; 38():101043. PubMed ID: 38226203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
    Sagen JV; Raeder H; Hathout E; Shehadeh N; Gudmundsson K; Baevre H; Abuelo D; Phornphutkul C; Molnes J; Bell GI; Gloyn AL; Hattersley AT; Molven A; Søvik O; Njølstad PR
    Diabetes; 2004 Oct; 53(10):2713-8. PubMed ID: 15448106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
    Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
    Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.